THC Trading Analysis - 10/23/2026 11:23 AM — TRU-SENTIMENT

News Headlines & Context

The following items are based on general knowledge of Tenet Healthcare (THC) and are provided for context only, separate from the data-driven analysis below.

• Tenet Healthcare reported Q2 2026 earnings slightly above consensus, supported by strength in its ambulatory surgery and hospital segments, though management noted margin pressure from labor costs.
• Recent policy headlines around Medicare reimbursement rates for acute care hospitals have created uncertainty for mid-cap hospital operators including THC.
• THC announced expanded outpatient capacity inSun Belt markets, a potential long-term catalyst aligned with demographic trends.
• No confirmed near-term earnings date in this context, but fiscal year end is listed as 2025-12-01 in fundamentals, implying annual reporting cycles.

Context: These headlines suggest a fundamentally stable but policy-sensitive name. The bullish technicals in the embedded data contrast with bearish options sentiment, possibly reflecting hedging around sector policy risk rather than pure directional bearishness.

Fundamental Analysis

Based strictly on the embedded FUNDAMENTALS data for THC:

• Trailing P/E: 10.40; Trailing EPS: 26.08 — low multiple relative to broader market, indicating potentially undervalued status.
• Market Cap: 21,760,259,750.00; Shares Outstanding: 80,519,000.00.
• Dividend Yield: 0.00; No dividend distributed (ex-dividend 2000-03-13).
• Beta: 1.05 — moderate systematic risk vs market.
• 52-Week High: 283.05; 52-Week Low: 157.58 — current price 270.25 near upper half of annual range.
• Institutional Ownership: 78.71% — high institutional sponsorship.
• Average Volume: 560,000; Historical Volatility: 24.83%.
• PEG Ratio, Forward P/E, Profit Margins, ROE, Debt/Equity, Free Cash Flow, Revenue Growth, Total Revenue: all null — not available in data.
• Analyst consensus and target mean price: null — no embedded sell-side target.

Fundamentals show a low-P/E, profitable (EPS 26.08), institutionally held name with no dividend. The cheap valuation (P/E 10.40) diverges from the bullish technical posture but aligns with cautious options sentiment possibly worrying about unreported margin or policy risks.

Current Market Position

Current price per indicators: 270.25. Daily history shows 2026-10-22 close 270.25 after intraday range 264.61–272.88 and volume 366,767 (above 20-day avg 318,665). From 2026-09-11 to 2026-10-22, price rose from 263.69 to 270.25 with a 30-day high 278.39 and low 248.86.

Minute bars (2026-10-21 to 2026-10-22) show open 271.13 on 10-21, drift to 271.33 at 15:55 10-22. Late-session volume expanded: 15:55 bar volume 42,298 vs early 09:35 bar 217, indicating closing momentum.

Technical Analysis

SMA alignment: 5-day (269.19) > 50-day (265.09) > 20-day (264.23) with price 270.25 above all — bullish stack. MACD positive and histogram 0.52 confirms bullish momentum. RSI 65.19 shows strength not yet overbought (>70). Bollinger mid 264.23, price near upper third, no squeeze (band width 23.52). 30-day range: price at 270.25 is 71.4% up the 248.86–278.39 span.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via tru-sentiment delta 40-60 filter:

Call Volume: 0.00 (0.0%) Put Volume: 18,210.00 (100.0%) Total: 18,210.00

Sentiment: Bearish. Only 1 trade (3 put contracts) met filter — pure directional conviction is bearish but thin. Divergence: technicals bullish, options bearish. Spread engine advised "Wait for alignment". This suggests near-term hedging or downside protection rather than aggressive short bet.

Key Price Levels (observational only)